Your browser doesn't support javascript.
loading
A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia.
Cantoni, Nathan; Sommavilla, Roberto; Seitz, Patrick; Kulenkampff, Elisabeth; Kahn, Stefan; Lambert, Jean-François; Schmidt, Adrian; Zenhaeusern, Reinhard; Balabanov, Stefan.
Affiliation
  • Cantoni N; Kantonsspital Aarau, Aarau, Switzerland.
  • Sommavilla R; Novartis Pharma Schweiz, Rotkreuz, Switzerland.
  • Seitz P; Novartis Pharma Schweiz, Rotkreuz, Switzerland.
  • Kulenkampff E; Novartis Pharma Schweiz, Rotkreuz, Switzerland.
  • Kahn S; Novartis Pharma Schweiz, Rotkreuz, Switzerland.
  • Lambert JF; Hôpital de Nyon, Nyon, Switzerland.
  • Schmidt A; Stadtspital Zürich Triemli, Zürich, Switzerland.
  • Zenhaeusern R; Spitalzentrum Oberwallis, Brig, Switzerland.
  • Balabanov S; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zürich, Switzerland. stefan.balabanov@usz.ch.
BMC Cancer ; 22(1): 1192, 2022 Nov 19.
Article in En | MEDLINE | ID: mdl-36402993
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Protein Kinase Inhibitors Type of study: Guideline / Observational_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Protein Kinase Inhibitors Type of study: Guideline / Observational_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Switzerland